Mark Trusheim, MIT, to Present at GTCbio's Inaugural Precision Medicine Conference

Top Quote Mark Trusheim, MIT to present, "Implementing Precision Medicine, Determining Economic Value under Adaptive Biomedical Innovation Pathways" at the Inaugural Precision Medicine Conference. End Quote
  • (1888PressRelease) June 11, 2016 - Mark Trusheim, Visiting Scientist of Applied Economics at the MIT Sloan School of Management, will give a presentation on "Implementing Precision Medicine, Determining Economic Value under Adaptive Biomedical Innovation Pathways" at GTCbio's Inaugural Precision Medicine Conference to be held on July 7-8, 2016 in Boston, MA.

    Precision medicines, increased regulatory pathway innovation (EMA Adaptive Pathways and FDA Breakthrough/Accelerated Approval), and evolving payer approaches stressing pay-for-performance transform the economics for innovators, patients and payers. Will these dynamics break the biomedical innovation chain or lead to a new sustainable path for all?

    In this session, participants will explore how precision medicine and adaptive biomedical innovation pathways are transforming:
    * Clinical development platforms, cost and speed
    * Real world evidence use for determining clinical and economic value
    * Market access timing, growth and pricing
    * Capabilities to execute managed entry and pay-for-performance
    * Application of precision medicine to legacy treatments as well as new

    This conference brings together multiple stakeholders with a holistic view of the precision medicine landscape to discuss the future of healthcare. The summit will bring together an exciting balance of industry, academia, and government so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective in precision medicine!

    Session Topics:
    I. Overcoming Challenges in the Commercialization of Precision Medicine
    II. Implementation of Precision Medicine: Strategies & Technologies
    III. Precision Medicine Beyond Oncology
    IV. Integrating & Interpreting Personal Genomics, Big Data, & Bioinformatics
    V. Incentivizing Precision Medicine: Regulation & Reimbursement

    This conference is also part of our larger Molecular Diagnostics Summit, which includes two additional conferences:
    -Precision Medicine
    -2nd Cancer Markers & Liquid Biopsies
    -Digital PCR & qPCR

    For more information, please visit website:

    635 W. Foothill Blvd
    Monrovia, CA 91016
    Email: infogtcbio ( @ ) gtcbio dot com
    Phone: (626) 256-6405
    Fax: (626) 466-4433

  • FB Icon Twitter Icon In-Icon
Contact Information